Cipta Sarana Medika Tbk. vs Kalbe Farma Tbk — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Kalbe Farma Tbk trades at Rp705 (market cap 34.17T, 156.61M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 216.1× Cipta Sarana Medika Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (156.61M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | KLBF | |
|---|---|---|
Market Cap | 158.12B | 34.17T |
Volume | 8.21M | 156.61M |
Lot | 82.15K | 1.57M |
Turnover | 515.2M | 111.23B |
Average Price | 62.72 | 710.21 |
Value | 515.2M | 111.23B |
Indicative Equilibrium Price | 63 | 705 |
Indicative Equilibrium Volume | 1.33K | 56.1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →